EastWest Bioscience Performance
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and EastWest Bioscience are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days EastWest Bioscience has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, EastWest Bioscience is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 107.1 K | |
| Total Cashflows From Investing Activities | 21 K |
EastWest |
EastWest Bioscience Relative Risk vs. Return Landscape
If you would invest (100.00) in EastWest Bioscience on October 14, 2025 and sell it today you would earn a total of 100.00 from holding EastWest Bioscience or generate -100.0% return on investment over 90 days. EastWest Bioscience is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded stocks are less volatile than EastWest, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
EastWest Bioscience Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for EastWest Bioscience's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as EastWest Bioscience, and traders can use it to determine the average amount a EastWest Bioscience's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| HBOSF |
Based on monthly moving average EastWest Bioscience is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of EastWest Bioscience by adding EastWest Bioscience to a well-diversified portfolio.
EastWest Bioscience Fundamentals Growth
EastWest Stock prices reflect investors' perceptions of the future prospects and financial health of EastWest Bioscience, and EastWest Bioscience fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on EastWest Stock performance.
| Return On Equity | -4.0E-4 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | (3.40) % | |||
| Current Valuation | 3.28 M | |||
| Shares Outstanding | 92.61 M | |||
| Price To Earning | 3.57 X | |||
| Price To Book | 0.57 X | |||
| Price To Sales | 1.58 X | |||
| Revenue | 626.56 K | |||
| EBITDA | (1.25 M) | |||
| Cash And Equivalents | 19.97 K | |||
| Total Debt | 368.4 K | |||
| Debt To Equity | 0.72 % | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | (688.47 K) | |||
| Earnings Per Share | 0 X | |||
| Total Asset | 3.72 M | |||
Things to note about EastWest Bioscience performance evaluation
Checking the ongoing alerts about EastWest Bioscience for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for EastWest Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| EastWest Bioscience is not yet fully synchronised with the market data | |
| EastWest Bioscience has some characteristics of a very speculative penny stock | |
| EastWest Bioscience has a very high chance of going through financial distress in the upcoming years | |
| EastWest Bioscience has accumulated 368.4 K in total debt with debt to equity ratio (D/E) of 0.72, which is about average as compared to similar companies. EastWest Bioscience has a current ratio of 0.09, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about EastWest Bioscience's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the revenue of 626.56 K. Net Loss for the year was (1.61 M) with profit before overhead, payroll, taxes, and interest of 527.6 K. | |
| EastWest Bioscience has accumulated about 19.97 K in cash with (688.47 K) of positive cash flow from operations. | |
| Roughly 31.0% of EastWest Bioscience shares are held by company insiders |
- Analyzing EastWest Bioscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether EastWest Bioscience's stock is overvalued or undervalued compared to its peers.
- Examining EastWest Bioscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating EastWest Bioscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of EastWest Bioscience's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of EastWest Bioscience's stock. These opinions can provide insight into EastWest Bioscience's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in EastWest Stock
If you are still planning to invest in EastWest Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EastWest Bioscience's history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |